IGF1R and non-small cell lung carcinoma: Thus we previously showed that blocking IGF-1R signaling in NSCLC cells in vitro by the Tyrosine kinase inhibitor (TKI) AG1024 inhibited downstream proliferative signaling via Akt and resulted in cell death [23, 24].